Zenomics

About:

Zenomics is developing a microneedle transdermal patch technology for diabetes

Website: https://www.zenomicsbio.com/

Description:

Zenomics is developing a microneedle transdermal patch technology for diabetes, which is able to sense blood glucose levels and respond with appropriate concentrations of insulin. The company's drug delivery patch senses blood glucose levels and responds with appropriate concentrations of insulin. The company was founded in 2015 and is headquartered in Durham, North Carolina.